U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Oxalobacter formigenes HC-1

MORE DETAILS

W0KQL6X5JI

structurally diverse
Status:
Investigational
Source:
NCT01037231: Phase 2/Phase 3 Interventional Completed Primary Hyperoxaluria
(2009)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT01037231
Class:
STRUCTURALLY DIVERSE

Oxalobacter formigenes

MORE DETAILS

330ZY4KI6F

structurally diverse
Status:
Designated
Source:
FDA ORPHAN DRUG:219206
Source URL:
https://ginas.ncats.nih.gov/ginas/app/substance/330ZY4KI6F
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966